The document discusses American Water, the largest publicly traded water and wastewater utility company in the United States. It provides an overview of American Water's business, including its market capitalization, revenues, regulated and market-based segments, and growth strategies. American Water aims to invest $1 billion annually in its regulated operations and achieve long-term 7-10% earnings growth through regulated infrastructure spending and acquisitions as well as its market-based business opportunities.
Founded in 1886, American Water (NYSE: AWK) is the largest publicly traded U.S. water and wastewater utility company. With headquarters in Voorhees, N.J., the company employs approximately 6,600 dedicated professionals who provide drinking water, wastewater and other related services to an estimated 14 million people in more than 40 states and parts of Canada. Our January Online Conference was attended by nearly 5,000 investors. Don't miss your chance to listen to leading small-cap company executives who will provide detailed overviews of their businesses through video presentations and live Q&A sessions.
Founded in 1886, American Water (NYSE: AWK) is the largest publicly traded U.S. water and wastewater utility company. With headquarters in Voorhees, N.J., the company employs approximately 6,600 dedicated professionals who provide drinking water, wastewater and other related services to an estimated 14 million people in more than 40 states and parts of Canada. Our January Online Conference was attended by nearly 5,000 investors. Don't miss your chance to listen to leading small-cap company executives who will provide detailed overviews of their businesses through video presentations and live Q&A sessions.
American Water, through its subsidiaries, provides high-quality water and wastewater services to approximately 15 million people in more than 47 states, as well as parts of Canada. Headquartered in Voorhees, NJ, we are the largest publicly traded water and wastewater utility company in the United States, and are the parent company to our state subsidiaries. We employ more than 6,400 people who give back to the community each day by doing their part to provide the highest quality service possible. Our professionals are committed to customer service, operational excellence and the delivery of high-quality, reliable drinking water, safe and effective wastewater treatment and release and other water-related management services. Our teams live and work in the communities they serve.
American Water, through its subsidiaries, provides high-quality water and wastewater services to approximately 15 million people in more than 47 states, as well as parts of Canada. Headquartered in Voorhees, NJ, we are the largest publicly traded water and wastewater utility company in the United States, and are the parent company to our state subsidiaries. We employ more than 6,400 people who give back to the community each day by doing their part to provide the highest quality service possible. Our professionals are committed to customer service, operational excellence and the delivery of high-quality, reliable drinking water, safe and effective wastewater treatment and release and other water-related management services. Our teams live and work in the communities they serve.
Access Midstream Partners Investor Presentation - July 2013 Kprelosky
Headquartered in Oklahoma City, Access Midstream Partners is one of the largest midstream gathering companies in the U.S. with a diverse mix of gathering pipelines and facilities in the most attractive producing regions in North America.
Access Midstream has established a large-scale position in all of the key unconventional basins in the U.S. and has broad exposure to gathering opportunities in liquids-rich regions with extended access to the processing and fractionation segments of the midstream value chain. Access's diverse portfolio of assets are strategically located in 12 states that encompass the prolific Barnett, Eagle Ford, Haynesville, Marcellus, Niobrara and Utica shales, and Mid-Continent areas.
Access Midstream's gathering systems are comprised of more than 6,000 miles of active gathering and transmission lines and treating facilities that provide services to approximately 7,900 wells. Our assets gather approximately 3.5 billion cubic feet (Bcf) of natural gas per day, which we believe ranks us as the largest gathering and processing master limited partnership in the U.S.
The earnings PowerPoint slide deck used during an earnings call for NFG to highlight their fourth quarter and full year performance. NFG includes Seneca Resources (drilling subsidiary) and Empire Pipeline (midstream subsidiary).
Based in Ann Arbor, Michigan, Zomedica is a veterinary health company creating diagnostic and therapeutic products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. With modest cash burn and a strong balance sheet, including $142.4 million cash and cash equivalents as of June 30, 2023, Zomedica is well-positioned to fund both organic growth and acquisitions.
Dócola is a social good organization with the only free care communication platform that consolidates thousands of free and low-cost patient education resources from the leading nonprofit, government, and commercial organizations in one marketplace. Plus, you can easily create and upload your own resources.
INNO HOLDINGS INC. is an innovative building-technology company with a mission to transform the construction industry with our proprietary cold-formed steel- framing technology and other building innovations
Everything Blockchain builds platforms of trust for the modern enterprise and is on a mission to ensure every organization has access to the tools and platforms that enable them to manage, store, and protect data without the cost and complexity that holds them back today. The Company’s patented advances in engineering deliver the essential elements needed for real-world business use: speed, security, and efficiency. Everything Blockchain’s current business lines include: EB Advise, Build DB and EB Control.
ASP Isotope is an isotope enrichment company utilizing technology developed in South Africa over the past 20 years to enrich isotopes of elements or molecules with low atomic masses. Many of these elements are unsuitable for enrichment using traditional methods such as centrifuges. The Company’s initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries.
MDNA Life Sciences is a pioneer in the science of mitochondrial DNA. It’s our mission to create an extensive portfolio of proprietary tests that dramatically improve diagnosis, treatment, prognosis and monitoring. Putting an end to the unnecessary surgical procedures, pain and uncertainty that affect patients across the world.
Digital Ally, Inc. is a diversified holding company with operations in video solution technology, human and animal health protection products, healthcare revenue cycle management, ticket brokering and marketing, and event production. The Company pursues an acquisition strategy that targets organizations with positive earnings, strong growth potential, innovation, and operational synergies. To maximize long-term shareholder value, Digital Ally intends to spin-off its ticketing and entertainment business lines into a separate public company in 2023. The spin-off will create two optimized, tech-driven public companies with strong growth opportunities and operating metrics.
Lantern Pharma is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Our proprietary AI and machine learning (ML) platform, RADR®, leverages over 25 billion oncology-focused data points and a library of 200+ advanced ML algorithms to help solve billion-dollar, real-world problems in oncology drug development. By harnessing the power of AI and with input from world-class scientific advisors and collaborators, we have accelerated the development of our growing pipeline of therapies including eleven cancer indications and an antibody-drug conjugate (ADC) program. On average, our newly developed drug programs have been advanced from initial AI insights to first-in-human clinical trials in 2-3 years and at approximately $1.0-2.0 million per program.
Sharps Technology is a medical device and pharmaceutical packaging company specializing in the development and manufacturing of innovative drug delivery systems. The Company’s product lines focus on low waste and ultra-low waste syringe technologies that incorporate both passive and active safety features. These features protect front line healthcare workers from life-threatening needle stick injuries and protect the public from needle re-use. Sharps Technology has extensive expertise in specialized prefilled syringe systems and is on track to launch this new product line in Q4 2023. The Company has a manufacturing facility in Hungary and has partnered with Nephron Pharmaceuticals to expand its manufacturing capacity in the US.
Aditxt is a global innovation company focused on discovering and developing precision medicine innovations and deploying them into high-performing businesses. Aditxt’s diverse innovation portfolio includes: Adimune™, Inc., developing and designing a new class of therapeutics for retraining the immune system to address organ rejection, autoimmunity, and allergies; Adivir™, Inc., focused on identifying, developing and commercializing new ways to treat infectious diseases; and Pearsanta™, Inc., offering convenient, rapid, personalized, and high-quality lab testing —anytime and anywhere at its CLIA certified and CAP accredited clinical laboratory based in Richmond, VA.
1847 Holdings LLC, a publicly traded diversified acquisition holding company, was founded by Ellery W. Roberts, a former partner of Parallel Investment Partners, Saunders Karp & Megrue and Principal of Lazard Freres Strategic Realty Investors. EFSH's investment thesis is that capital market inefficiencies have left the founders and/or stakeholders of many small business enterprises and lower-middle market businesses with limited exit options, despite the intrinsic value of their business. Given this dynamic, EFSH can consistently acquire "solid" businesses for reasonable multiples of cash flow and then deploy resources to strengthen the infrastructure and systems to improve operations. These improvements may lead to a sale or IPO of an operating subsidiary at considerably higher valuations than the purchase price (as successfully demonstrated with the mid-2020 IPO of 1847 Goedeker on the NYSE American) and/or alternatively, an operating subsidiary may be held in perpetuity and contribute to EFSH's ability to pay regular and special dividends to shareholders.
Sharps Technology is a medical device and pharmaceutical packaging company specializing in the development and manufacturing of innovative drug delivery systems. The Company’s product lines focus on low waste and ultra-low waste syringe technologies that incorporate both passive and active safety features. These features protect front line healthcare workers from life-threatening needle stick injuries and protect the public from needle re-use. Sharps Technology has extensive expertise in specialized prefilled syringe systems and is on track to launch this new product line in Q4 2023. The Company has a manufacturing facility in Hungary and has partnered with Nephron Pharmaceuticals to expand its manufacturing capacity in the US.
SPI Energy is a global renewable energy company and provider of solar storage and electric vehicle (EV) solutions that was founded in 2006 in Roseville, California and is headquartered in McClellan Park, California. The Company has three core divisions: SolarJuice which has solar wholesale distribution, as well as residential solar and roofing installation and solar module manufacturing (Solar4America & SEM Wafertech), SPI Solar and Orange Power which operates a commercial & utility solar division, and the EdisonFuture/Phoenix Motor EV division. SolarJuice is the leader in renewable energy system solutions for residential and small commercial markets and has extensive operations in the Asia Pacific and North America markets. The SPI Solar commercial & utility solar division provides a full spectrum of EPC services to third party project developers, and develops, owns and operates solar projects that sell electricity to the grid in multiple regions, including the U.S., U.K., and Europe. Phoenix Motor is a leader in medium-duty commercial electric vehicles, and is developing EV charger solutions, electric pickup trucks, electric forklifts, and other EV products. SPI maintains global operations in North America, Australia, Asia and Europe and is also targeting strategic investment opportunities in fast growing green energy industries such as battery storage, charging stations, and other EVs which leverage the Company's expertise and substantial solar cash flow.
BullFrog AI is a technology enabled drug development company using machine learning to usher in a new era of precision medicine. Through its collaborations with leading research institutions, including Johns Hopkins University and J. Craig Venter Institute, BullFrog AI is at the forefront of AI-driven drug development. Using its proprietary bfLEAP™ artificial intelligence platform, BullFrog AI aims to enable the successful development of pharmaceuticals and biologics by predicting which patients will respond to therapies in development. BullFrog AI is deploying bfLEAP™ for use at several critical stages of development with the intention of streamlining data analytics in therapeutics development, decreasing the overall development costs by decreasing failure rates for new therapeutics, and impacting the lives of countless patients that may have otherwise not received the therapies they need.
BullFrog AI is a technology enabled drug development company using machine learning to usher in a new era of precision medicine. Through its collaborations with leading research institutions, including Johns Hopkins University and J. Craig Venter Institute, BullFrog AI is at the forefront of AI-driven drug development. Using its proprietary bfLEAP™ artificial intelligence platform, BullFrog AI aims to enable the successful development of pharmaceuticals and biologics by predicting which patients will respond to therapies in development. BullFrog AI is deploying bfLEAP™ for use at several critical stages of development with the intention of streamlining data analytics in therapeutics development, decreasing the overall development costs by decreasing failure rates for new therapeutics, and impacting the lives of countless patients that may have otherwise not received the therapies they need.
BioVie is a clinical-stage company developing what it believes will be transformative therapies to overcome unmet medical needs in neurodegeneration and liver disease. The Company is developing NE3107 for Alzheimer’s (AD) and Parkinson’s (PD) and BIV201 for refractory ascites and HRS-AKI.
Lantern Pharma is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Our proprietary AI and machine learning (ML) platform, RADR®, leverages over 25 billion oncology-focused data points and a library of 200+ advanced ML algorithms to help solve billion-dollar, real-world problems in oncology drug development. By harnessing the power of AI and with input from world-class scientific advisors and collaborators, we have accelerated the development of our growing pipeline of therapies including eleven cancer indications and an antibody-drug conjugate (ADC) program. On average, our newly developed drug programs have been advanced from initial AI insights to first-in-human clinical trials in 2-3 years and at approximately $1.0-2.0 million per program.
Genetic Technologies is a diversified molecular diagnostics company. A global leader in genomics-based tests in health, wellness and serious disease through its geneType and EasyDNA brands. GENE offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The Company has a proprietary risk stratification platform that has been developed over the past decade and integrates clinical and genetic risk to deliver actionable outcomes to physicians and individuals. Leading the world in risk prediction in oncology, cardiovascular and metabolic diseases, Genetic Technologies continues to develop risk assessment products.
Splash Beverage Group, an innovator in the beverage industry, owns a growing portfolio of alcoholic and non-alcoholic beverage brands including Copa di Vino wines by the glass, SALT naturally flavored tequilas, Pulpoloco Sangria, and TapouT performance hydration and recovery drinks and TapouT Cognitive Energy Drink. Splash’s strategy is to rapidly develop early-stage brands already in its portfolio as well as acquire and then accelerate brands that have high visibility or are innovators in their categories. Led by a management team that has built and managed some of the top brands in the beverage industry and led sales from product launch into the billions, Splash is rapidly expanding its brand portfolio and global distribution.
Splash Beverage Group, an innovator in the beverage industry, owns a growing portfolio of alcoholic and non-alcoholic beverage brands including Copa di Vino wines by the glass, SALT naturally flavored tequilas, Pulpoloco Sangria, and TapouT performance hydration and recovery drinks and TapouT Cognitive Energy Drink. Splash’s strategy is to rapidly develop early-stage brands already in its portfolio as well as acquire and then accelerate brands that have high visibility or are innovators in their categories. Led by a management team that has built and managed some of the top brands in the beverage industry and led sales from product launch into the billions, Splash is rapidly expanding its brand portfolio and global distribution.
Osisko Development - Investor Presentation - June 24
Awk red chip slides final without notes
1. NYSE: AWK
American Water
Durgesh Chopra
Director Investor Relations
October 2014
2. Cautionary Statement Concerning Forward-Looking
Statements
Certain statements in this presentation are forward-looking statements within the meaning of the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995. These forward-looking statements are predictions based on American Water’s
current expectations and assumptions regarding future events and may relate to, among other things, its future financial
performance, including earnings, growth and portfolio optimization strategies, its ability to finance current operations and growth
initiatives, trends in its industry, regulatory or legal developments or rate adjustments. Actual results could differ materially
because of factors such as the decisions of governmental and regulatory bodies, including decisions to raise or lower rates; the
timeliness of regulatory commissions’ actions concerning rates; changes in laws, governmental regulations and policies,
including environmental, health and water quality, and public utility regulations and policies; the outcome of litigation and
government action related to the Freedom Industries chemical spill in West Virginia; weather conditions, patterns or events,
including drought or abnormally high rainfall, strong winds and coastal and intercoastal flooding; changes in customer demand
for, and patterns of use of, water, such as may result from conservation efforts; its ability to appropriately maintain current
infrastructure and manage the expansion of its business; its ability to obtain permits and other approvals for projects; changes in
its capital requirements; its ability to control operating expenses and to achieve efficiencies in its operations; its ability to obtain
adequate and cost-effective supplies of chemicals, electricity, fuel, water and other raw materials that are needed for its
operations; its ability to successfully acquire and integrate water and wastewater systems that are complementary to its
operations and the growth of its business, including, among other core growth opportunities, concession arrangements and
agreements for the provision of water services in the unregulated shale arena; cost overruns relating to improvements or the
expansion of its operations; changes in general economic, business and financial market conditions; access to sufficient capital
on satisfactory terms; fluctuations in interest rates; restrictive covenants in or changes to the credit ratings on the company’s
current or future debt that could increase its financing costs or affect its ability to borrow, make payments on debt or pay
dividends; fluctuations in the value of benefit plan assets and liabilities that could increase its cost and funding requirements;
migration of customers into or out of its service territories; difficulty in obtaining insurance at acceptable rates and on acceptable
terms and conditions; its ability to retain and attract qualified employees; cash impact if the National Labor Relations Board order
requiring it to provide back pay to employees in connection with a dispute relating to its national benefits agreements with unions
representing Regulated Businesses employees is upheld on appeal; labor actions including work stoppages and strikes; the
incurrence of impairment charges; and civil disturbance, terrorist threats or acts, or public apprehension about future
disturbances or terrorist threats or acts.
For further information regarding risks and uncertainties associated with American Water’s business, please refer to American
Water’s annual, quarterly and current SEC filings. The company undertakes no duty to update any forward-looking statement.
October 2014
NYSE: AWK www.amwater.com 2
3. October 2014
Water Industry Basics: The US Water Industry is highly
fragmented and with limited Investor ownership
Percentage of Drinking Water Systems and
Population served by Size Class (1)
(Based on 51,988 total water systems in US)
System Size bbyy PPooppuullaattiioonn SSeerrvveedd
(1) Source: EPA, Drinking and Ground Water Statistics, 2008.
Water
Wastewater
Investor
Owned
16%
Public &
Other
84%
Investor
Owned
2%
Public &
Other
98%
The majority of water systems in the US are owned by capital constrained entities
NYSE: AWK www.amwater.com 3
4. October 2014
Aging U.S Pipe Infrastructure Network Propels Need
for Capital Expenditures
Without renewal or replacement of existing systems, pipe
classified as poor, very poor or life elapsed will increase from
Without renewal or replacement of existing systems, pipe
classified as poor, very poor or life elapsed will increase from
10% of pipes in the U.S. to 44% by 2020
10% of pipes in the U.S. to 44% by 2020
Wooden water
pipes
Water main break
NYSE: AWK www.amwater.com 4
Corroded water pipe
5. American Water: The Premier Water Services Provider
in North America
$14.6 Billion Total Enterprise Value
700,000 Average Trading Volume
$8.6 Billion Market Capitalization
$2.9 Billion in 2013 Revenues
89% Regulated, 11% Market Based
21.6% Total Shareholder Return for Last 12
21.6% Total Shareholder Return for Last 12
October 2014
$14.6 Billion Total Enterprise Value
700,000 Average Trading Volume
$8.6 Billion Market Capitalization
$2.9 Billion in 2013 Revenues
89% Regulated, 11% Market Based
Months
Months
2.6% Current Dividend Yield
0.8 Beta
2.6% Current Dividend Yield
0.8 Beta
14 Million People Served
47,000 Miles of Pipeline
6,600 Employees
1,500 Communities
3.2 Million Regulated Customers
14 Million People Served
47,000 Miles of Pipeline
6,600 Employees
1,500 Communities
3.2 Million Regulated Customers
Market
Statistics*
Assets
* Market data as of September 25, 2014, Source : FactSet
NYSE: AWK www.amwater.com 5
6. October 2014
We have delivered impressive total shareholder value
since 2008 IPO
$350
$300
$250
$200
$150
$100
Total Shareholder Return History: IPO – Sep 25, 2014
NYSE: AWK www.amwater.com 6
Source: Factset, Bloomberg
Our Total Shareholder Return has outperformed S&P500
and Utility Peers
As of Sep 25, 2014
One Year Three Year Five Year
American Water
Price Appreciation 18.4% 61.9% 144.4%
Including Dividend 21.6% 75.7% 185.1%
UTY Index
Price Appreciation 9.2% 18.7% 34.5%
Including Dividend 13.5% 34.3% 66.6%
S&P500
Price Appreciation 16.1% 73.0% 88.2%
Including Dividend 18.6% 84.6% 109.1%
A $100 dollar investment in American Water at
IPO would have increased approximately 3x
$50
Total Shareholder Return
7. October 2014
Our Long Term 7- 10% EPS Growth Plan: Regulated Growth
Opportunities while leveraging Market Based Businesses
MBB
(<1%)
Other
Shale
(0-2%)
Market Based
(2-3%)
Regulated Acquisitions
(1-2%)
Long-term Plan
2015 - 2018
Regulated Investment – CapEx
(4-5%)
Regulated Investment – CapEx
(3-5%)
Market Based Growth: 2%-5%
NYSE: AWK www.amwater.com 7
Note: * Net of Declining Usage
Regulated Growth: 4%-7%
8. October 2014
Our Regulated Business
549,892
483,876
378,635
369,892
195,824
1.2 million
1.5 million
NYSE: AWK www.amwater.com 8
New Jersey
Pennsylvania
Missouri
Illinois
Indiana
California
West Virginia
Kentucky
Tennessee
Virginia
New York
Iowa
All Other
57,566
361,864
644,865
1.2 million
2.1 million
2.5 million
States Where We Operate
(approximate population served by state )*
* Population data for FY 2013
State
FY 2013
Revenues
($ mm)
% of
Total
New Jersey $638.0 24.6%
Pennsylvania 571.2 22.0%
Missouri 264.8 10.2%
Illinois 261.7 10.1%
California 209.5 8.1%
Indiana 199.2 7.7%
West Virginia 124.2 4.8%
Other 325.3 12.5%
Total Regulated Business $2,593.9 100%
9. October 2014
We will invest approximately $1 Billion per year in our
core growth Regulated Operations
Capital Expenditures
($ in millions)
NYSE: AWK www.amwater.com 9
$1,200
$1,000
$800
$600
$400
$200
$0
2012 Actual 2013 Actual 2014E 2015E 2016E 2017E 2018E
10. Cost containment and timely return on our investments
will drive added Capital Expenditures
American Water Pipe Replacement Rate
(in years)
National
average
2010 2011 2012 2013 2014E
October 2014
300
250
200
150
100
50
0
O&M Efficiency Ratio
O&M stretch target of 35% by 2018 Pipe Replacement rate is shortening
NYSE: AWK www.amwater.com 10
44.2 42.4
40.1 38.7
35.0
50%
40%
30%
20%
10%
0%
2010 2011 2012 2013 2018 Stretch
Target
O&M Efficiency Ratio*
*Non GAAP Measure – See appendix for reconciliation
11. Disciplined approach to O&M cost controls enables more
efficient use of our capital
Note:
*Approximation in states where we received black box award, as of May 2014
**For general rate cases effective in 2014, the incremental revenue requirement was reduced by 25% due to lower Operating expenditures.
October 2014
Incremental Revenue Requirement*
– Increases Attributable to Opex vs. Capex –
NYSE: AWK www.amwater.com 11
12. Market Based Business generate complementary opportunities
for growth
October 2014
Regulated Like
Except not as Capital Intensive
Lines of Business
•Homeowner Services (HOS)
•Contract Operations
• Military Services Group (MSG)
• Municipal/Industrial (CSG)
•Biosolids / Terratec
•Modest competition
•Strong/consistent margins
•Controllable risk
•Growing market
•Capitalizes on AW strengths
Note: MBB segment also includes two non-regulated contracts for NJ concessions which are not included in this presentation
NYSE: AWK www.amwater.com 12
13. October 2014
Business Updates
Commitment to Our Customer
2013 Water Quality Report
•American Water again scored above 99% for compliance
with EPA standards
•20x better than industry average for compliance with drinking
water quality standards
•150x better than industry average for compliance with drinking
water reporting and monitoring requirements
Commitment to Innovation
Innovation Development Process - NPXpress
•Launched in 2009, our Innovation Development Process has
examined over 400 technologies to date
•NPXpress, licensed to Abengoa in April, 2014, is cost effective
way to remove nitrogen & phosphorus from wastewater
Commitment to Financial Stability
AWK Outlook changed from Stable to Positive
AWK Outlook changed from Stable to Positive
•American Water Works Co. Inc. And Subsidiaries Outlook
Revised To Positive; 'A-' Corporate Credit Ratings Affirmed
•American Water Works Co. Inc. And Subsidiaries Outlook
Revised To Positive; 'A-' Corporate Credit Ratings Affirmed
NYSE: AWK www.amwater.com 13
14. October 2014
American Water Update
American Water Named to the Dow
Jones Utility Average
American Water Named to the Dow
Jones Utility Average
• 15-member index that represents
• 15-member index that represents
the stock performance of large,
well-known U.S. companies within
the utilities sector
• Index Market Capitalization of
the stock performance of large,
well-known U.S. companies within
the utilities sector
• Index Market Capitalization of
approximately $400 Billion
• Since inception in 1929 only 40
approximately $400 Billion
• Since inception in 1929 only 40
companies have been part of the
Index
• American Water is the only Water
companies have been part of the
Index
• American Water is the only Water
& Waste Water Utility included in
the Index
& Waste Water Utility included in
the Index
NYSE: AWK www.amwater.com 14
15. Dividend Practice
• Future dividend
increases aligned
with normalized EPS
growth
• Payout ratio
between 50-60
percent of net
income
October 2014
Long History of Consistent Annual Dividend Growth
Announced $0.31 quarterly cash dividend per
common share payable September 2, 2014 to all
shareholders of record as of August 11, 2014
2008 2009 2010 2011 2012 2013 2014
* Source: Thomson Reuters, Time Period: 2009 – 2013 Dividend Paid CAGR
Peer companies include: AWR, WTR, CWT, ATO, GAS, WGL, GXP, WR, OGE, AEE, POR, LNT, EDE, SCG, POM, HE, IDA, TE, CMS, UNS, PNM.
NYSE: AWK www.amwater.com 15
$$00.2.200
$$00.2.211 $0.22 $0.22
$$00.2.233 $$00.2.255
$$00.2.288
$$00.3.311
Announced $0.31 quarterly cash dividend per
common share payable September 2, 2014 to all
shareholders of record as of August 11, 2014
CCAAGGRR 8 8%%
Top quartile Dividend CAGR Growth compared to water and utilities peers*
16. October 2014
Why American Water is the right investment for you
Our Mission: Safe, Clean, Affordable and Reliable Water
Services to Highly Satisfied Customers
• Operations in over 40 states, Regulated Presence in 16 states
• 5 Year EPS CAGR (2009 – 2013) approximately 16%
• Operational Efficiency 35% by 2018
• 5 Year Capex $5.8 Bn (Reg. $5.5 Bn), avg 2% annual bill increase
• Regulated like & Asset light
• Homeowner Services, Military, Municipal & Biosolids
• Innovation Development Process: NPXpress Patent
• 20x better industry avg (drinking water quality)
• 150x better industry avg (drinking water reporting & monitoring)
• Dividend growth correlated w/ EPS growth & Payout of 50%-60%
• Free cash flow positive by 2017
Industry Leading 7-10%
Long Term EPS Growth
Operational Excellence
Maximizes Investments &
Minimizes Bill Increases
Market Based Businesses
Build Adjacencies & Provide
Growth Opportunities
Commitment To Innovation
Commitment to
Environmental Stewardship
Transparent Dividend Practice
& No Planned Equity Offerings
NYSE: AWK www.amwater.com 16
17. October 2014
Investor Relations Contacts:
Investor Relations Contacts:
Ed Vallejo
Vice President – Investor Relations
Edward.vallejo@amwater.com
Durgesh Chopra
Director – Investor Relations
Durgesh.chopra@amwater.com
Ed Vallejo
Vice President – Investor Relations
Edward.vallejo@amwater.com
Durgesh Chopra
Director – Investor Relations
Durgesh.chopra@amwater.com
Tel: 856-566-4005
Fax: 856-782-2782
Tel: 856-566-4005
Fax: 856-782-2782
NYSE: AWK www.amwater.com 17